KR20060002331A - A method for preparing chitosan/poly -glutamic acid polyelectrolyte complex - Google Patents

A method for preparing chitosan/poly -glutamic acid polyelectrolyte complex Download PDF

Info

Publication number
KR20060002331A
KR20060002331A KR1020040051301A KR20040051301A KR20060002331A KR 20060002331 A KR20060002331 A KR 20060002331A KR 1020040051301 A KR1020040051301 A KR 1020040051301A KR 20040051301 A KR20040051301 A KR 20040051301A KR 20060002331 A KR20060002331 A KR 20060002331A
Authority
KR
South Korea
Prior art keywords
chitosan
glutamic acid
gamma glutamic
poly gamma
poly
Prior art date
Application number
KR1020040051301A
Other languages
Korean (ko)
Other versions
KR100691869B1 (en
Inventor
강학수
박세훈
서상봉
Original Assignee
주식회사 바이오폴
학교법인 중앙대학교
손태일
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 바이오폴, 학교법인 중앙대학교, 손태일 filed Critical 주식회사 바이오폴
Priority to KR1020040051301A priority Critical patent/KR100691869B1/en
Publication of KR20060002331A publication Critical patent/KR20060002331A/en
Application granted granted Critical
Publication of KR100691869B1 publication Critical patent/KR100691869B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/02Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
    • C08G69/36Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino acids, polyamines and polycarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/28Bones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/26Mixtures of macromolecular compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00Processes of treating or compounding macromolecular substances
    • C08J3/12Powdering or granulating

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

본 발명은 키토산/폴리 감마 글루탐산 고분자전해질 복합체의 제조방법에 관한 것으로, 키토산의 생체적합성, 항미생물성, 생분해성 등 우수한 기능을 간직하며, 키토산으로 스폰지나 필름 등을 만들 경우 나타나는 구조적, 물리적 결함을 극복하여 높은 기계적 특성, 구조적 균일성, 높은 세포 친화력, 높은 팽윤(swelling) 등의 우수한 성질을 나타내는 키토산/폴리 감마 글루탐산 고분자전해질 복합체의 제조방법을 제공하는 뛰어난 효과가 있다.The present invention relates to a method for producing a chitosan / poly gamma glutamic acid polymer electrolyte composite, and retains the excellent functions such as biocompatibility, antimicrobial, biodegradability of chitosan, structural and physical defects appearing when making a sponge or film with chitosan There is an excellent effect of providing a method for producing a chitosan / poly gamma glutamic acid polymer electrolyte composite exhibiting excellent properties such as high mechanical properties, structural uniformity, high cell affinity, high swelling, and the like.

또한, 본 발명 키토산/폴리 감마 글루탐산 고분자전해질 복합체는 상처의 드레싱, 세포배양용 스캐폴드, 인공신장의 혈액 투석막, 인공폐의 막, 각막이식재료 또는 콘택트렌즈재료, 조직적합성 및 혈액적합성재료 등의 다양한 분야에 응용될 수 있다.In addition, the present invention chitosan / poly gamma glutamic acid polyelectrolyte complex, such as wound dressing, cell culture scaffold, artificial kidney hemodialysis membrane, artificial lung membrane, corneal graft material or contact lens material, tissue compatibility and blood compatibility material It can be applied to various fields.

키토산, 폴리 감마 글루탐산, 고분자전해질 복합체, 스캐폴드, 필름Chitosan, Poly Gamma Glutamic Acid, Polymer Electrolyte Complex, Scaffold, Film

Description

키토산/폴리 감마 글루탐산 고분자전해질 복합체의 제조방법{A method for preparing chitosan/poly γ-glutamic acid polyelectrolyte complex}Method for preparing chitosan / poly gamma glutamic acid polyelectrolyte complex {A method for preparing chitosan / poly γ-glutamic acid polyelectrolyte complex}

도 1은 키토산/폴리 감마 글루탐산의 혼합비율에 따른 고분자전해질 복합체의 콜로이드(stable turbid dispersion) 형성 정도를 나타낸 그래프이다.1 is a graph showing the degree of colloid (stable turbid dispersion) formation of the polymer electrolyte complex according to the mixing ratio of chitosan / poly gamma glutamic acid.

도 2는 pH 변화에 따른 키토산/폴리 감마 글루탐산 고분자전해질 복합체의 콜로이드(stable turbid dispersion) 형성 정도를 나타낸 그래프이다.Figure 2 is a graph showing the degree of colloid (stable turbid dispersion) formation of chitosan / poly gamma glutamic acid polyelectrolyte complex with pH change.

도 3은 본 발명 콜로이드성 키토산/폴리 감마 글루탐산 고분자전해질 복합체로 제조된 스캐폴드의 SEM 사진도를 나타낸 것이다.Figure 3 shows a SEM photograph of the scaffold made of the present invention colloidal chitosan / poly gamma glutamic acid polyelectrolyte complex.

도 4는 본 발명 키토산/폴리 감마 글루탐산의 혼합비율에 따른 고분자전해질 복합체의 세공크기를 나타낸 그래프이다.Figure 4 is a graph showing the pore size of the polymer electrolyte composite according to the mixing ratio of chitosan / poly gamma glutamic acid of the present invention.

도 5는 본 발명 키토산/폴리 감마 글루탐산의 혼합비율에 따른 고분자전해질 복합체로 제조된 필름의 인장강도를 나타낸 그래프이다.5 is a graph showing the tensile strength of the film prepared with a polymer electrolyte composite according to the mixing ratio of chitosan / poly gamma glutamic acid of the present invention.

도 6은 본 발명 콜로이드성 키토산/폴리 감마 글루탐산 고분자전해질 복합체로 제조된 스캐폴드의 세포적합성을 측정한 그래프로써, (a)는 세포 부착을 측정한 결과를 나타낸 것이고, (b)는 세포 증식을 측정한 결과를 나타낸 것이다.Figure 6 is a graph measuring the cell suitability of the scaffold prepared with the colloidal chitosan / poly gamma glutamic acid polyelectrolyte complex of the present invention, (a) shows the results of measuring cell adhesion, (b) shows the cell proliferation The measurement results are shown.

본 발명은 키토산/폴리 감마 글루탐산 고분자전해질 복합체의 제조방법에 관한 것이다. 보다 상세하게는, 본 발명은 키토산의 생체적합성, 항 미생물성, 생분해성 등 우수한 기능을 간직하며, 키토산으로 스폰지나 필름 등을 만들 경우 나타나는 구조적, 물리적 결함을 극복하기 위하여 음이온성 고분자인 폴리 감마 글루탐산을 키토산에 블렌드시켜 고분자전해질 복합체라는 개념을 도입하여 높은 기계적 특성, 세포 친화력, 팽윤(swelling) 등의 우수한 성질을 가지는 생체재료의 제조방법에 관한 것이다.The present invention relates to a method for preparing chitosan / poly gamma glutamic acid polymer electrolyte composite. More specifically, the present invention retains excellent functions such as biocompatibility, antimicrobiality, and biodegradability of chitosan, and poly gamma, which is an anionic polymer, to overcome structural and physical defects that occur when sponges or films are made of chitosan. The present invention relates to a method for preparing a biomaterial having high properties such as high mechanical properties, cell affinity, swelling by introducing glutamic acid into chitosan and introducing a polymer electrolyte complex.

키토산이 생체적합성, 항 미생물성, 생분해성 등 우수한 기능을 가지고 있다는 것이 알려지면서 이에 대한 연구가 활발히 진행되어 왔다. 그러나 이들이 우수한 기능을 보유하고 있음에도 불구하고 이로부터 제조된 스캐폴드(scaffold)나 필름의 물리적 성질 또는 구조적인 결함 등의 문제점을 가지고 있기 때문에, 이러한 문제점을 해결하기 위하여 키토산과 다른 고분자와의 블렌드(blend)에 관한 연구가 활발히 진행되고 있다. As chitosan is known to have excellent functions such as biocompatibility, antimicrobial activity, and biodegradability, research on this has been actively conducted. However, even though they have excellent functions, they have problems such as scaffolds and films having physical properties or structural defects. Thus, in order to solve these problems, blends of chitosan with other polymers ( Blends are being actively researched.

키토산과 다른 고분자와 블렌드시키는 방법에는 음이온적 성질을 띠는 고분자와 양이온적 성질을 띠는 키토산과 고분자전해질 복합체를 형성시키는 것이 있다. 생체재료로서 고분자전해질 복합체가 응용된 것은 1960년대 Michaels등의 연구가 최초이다. 고분자전해질 복합체의 특징으로는 물과 전해질에 의하여 가소화되어 습윤 시 유연성을 가지며 이온흡착선택성, 이온교환성, 높은 물투과성, 전해질 및 수용성 저분자물질에 대해 높은 투과성을 나타낸다. 이러한 성질들을 이용하여 고 분자전해질 복합체 막은 인공신장의 혈액 투석막, 인공폐의 막으로서 높이 평가되고 있으며, 각막이식재료 또는 콘택트렌즈재료, 조직적합성 및 혈액적합성재료 등으로 의학적으로 활발히 연구되고 있다. 종래에는 키토산과 고분자전해질 복합체를 형성하기 위하여 음이온성 고분자로 카복실메틸 셀룰로우즈(carboxylmethyl cellulose), 덱스트란 설페이트(dextran sulfate), 알긴산(alginic acid), 폴리 비닐 알콜 설페이트(poly (vinyl alcohol) sulfate), 카복심 에틸 덱스트란(carboxym ethyldextran), 헤파린(heparin), 콜라겐(collagen), 폴리 아크릴 애시드(poly acrylic acid) 등이 사용되어 왔다.The method of blending chitosan and other polymers includes forming a polymer electrolyte complex with an anionic polymer and a chitosan having a cationic property. In the 1960s, Michaels et al. First applied a polymer electrolyte composite as a biomaterial. The polymer electrolyte composite is characterized by plasticization by water and electrolyte, so that it has flexibility when wetted, and exhibits high ion permeability selectivity, ion exchangeability, high water permeability, and high permeability to electrolyte and water-soluble low molecular materials. Using these properties, high molecular electrolyte complex membranes are highly regarded as hemodialysis membranes of artificial kidneys and membranes of artificial lungs, and are being actively researched as corneal graft materials or contact lens materials, tissue compatibility and blood compatibility materials. Conventionally, carboxylmethyl cellulose, dextran sulfate, alginic acid, polyvinyl alcohol sulfate as anionic polymers to form chitosan and a polymer electrolyte complex ), Carboxym ethyldextran, heparin, collagen, poly acrylic acid and the like have been used.

하지만 이러한 고분자를 키토산과 블렌드시킬 경우 폴리 아크릴 애시드(poly acrylic acid)와 같은 합성고분자일 경우에는 세포 친화력이 떨어지고 생분해성이 저하되며, 헤파린과 같은 천연고분자일 경우 비용이 상당히 높아지는 등의 문제점이 있었다.However, when the polymer is blended with chitosan, synthetic polymers such as poly acrylic acid have a problem of low cell affinity and biodegradability, and a high cost of natural polymers such as heparin. .

본 발명자들은 상기 선행 기술의 문제점을 해결하기 위하여 실험을 행한 결과, 폴리 감마 글루탐산(poly γ-glutamic acid)은 바실러스(bacillus)계통의 미생물에서 대량 분비되는 폴리 아크릴 애시드이기 때문에 비용이 저렴하며, 키토산과 고분자전해질 복합체 형성이 우수하고 생분해성이 우수하며, 세포 친화력도 증가한다는 것을 발견하게 되었다. 또한 이것으로 스폰지, 필름을 제조할 경우 균일한 세공 크기(pore size), 높은 기공성(porosity)과 기계적 특성(mechanical property)을 가지는 등의 우수한 성질을 갖게됨으로써 상처의 드레싱, 세포배양용 스캐폴드, 인공신장의 혈액 투석막, 인공폐의 막, 각막이식재료 또는 콘택트렌즈재료, 조직적 합성 및 혈액적합성재료 등의 다양한 분야에 사용될 수 있는 생체재료임을 발견하여 본 발명을 완성하기에 이르렀다. The inventors conducted experiments to solve the problems of the prior art, poly-gamma glutamic acid (poly γ-glutamic acid) is a low cost because it is a polyacrylic acid that is secreted in large quantities in microorganisms of the bacillus strain, chitosan And polymer electrolyte complex formation was found to be excellent, biodegradable, and increased cell affinity. In addition, when producing sponges and films, it has excellent properties such as uniform pore size, high porosity and mechanical properties, thereby allowing for dressing of wounds and scaffolds for cell culture. The present invention has been found to be a biomaterial that can be used in various fields such as hemodialysis membranes of artificial kidneys, membranes of artificial lungs, corneal graft materials or contact lens materials, histological synthesis, and blood compatibility materials.

따라서, 본 발명의 목적은 종래의 키토산과 고분자전해질의 복합체 제조 시 나타나는 세포 친화력 저하, 생분해성 저하 및 고비용에 관한 종래의 단점을 개선하는 키토산과 고분자전해질 복합체의 제조방법을 제공하고자 한다.Accordingly, an object of the present invention is to provide a method for preparing a chitosan and a polymer electrolyte composite that improves the conventional disadvantages related to the decrease in cell affinity, biodegradability and high cost in the preparation of a conventional chitosan and a polymer electrolyte complex.

본 발명의 상기 목적은 게, 새우등의 껍질로부터 얻은 키토산을 양이온성 고분자로 사용하고, 바실러스 속 균주 배양물에서 분리 정제하여 얻은 폴리 감마 글루탐산을 음이온성 고분자로 사용하여 이를 키토산과 폴리 감마 글루탐산의 혼합비율이 100:1∼100:30 또는 99:1∼70:30 w/v 또는 v/v %이 되도록 혼합하여 pH 4∼5에서 1 v/v% 아세트산에 최종 1 w/v%가 되도록 녹여 콜로이드성 키토산/폴리 감마 글루탐산 고분자전해질 복합체를 얻고 이를 이용하여 스캐폴드, 필름을 제조하여 기계적 특성 및 세포적합성을 조사함으로써 달성하였다.The object of the present invention is to mix chitosan and poly gamma glutamic acid by using chitosan obtained from the shell of crab, shrimp, etc. as a cationic polymer, and using poly gamma glutamic acid obtained by separation and purification in Bacillus strain culture as an anionic polymer. Mix so that the ratio is from 100: 1 to 100: 30 or 99: 1 to 70:30 w / v or v / v% and dissolve to 1 v / v% acetic acid at a pH of 4 to 5 to the final 1 w / v%. Colloidal chitosan / poly gamma glutamic acid polyelectrolyte was obtained to obtain a scaffold, a film using the same to achieve the mechanical properties and cell compatibility.

이하, 발명의 구성을 구체적으로 설명한다.EMBODIMENT OF THE INVENTION Hereinafter, the structure of invention is demonstrated concretely.

본 발명은 양이온성 고분자로서 키토산과 음이온성 고분자로서 폴리 감마 글루탐산을 일정 pH에서 일정비율로 혼합하여 콜로이드성 키토산/폴리 감마 글루탐산 고분자전해질 복합체를 얻는 단계; 상기 콜로이드성 고분자전해질 복합체를 이용하여 스캐폴드를 제조하는 단계; 상기 콜로이드성 고분자전해질 복합체를 이용하여 필름을 제조하고 이의 기계적 특성을 조사하는 단계; 및 상기에서 제조된 스캐폴드 를 이용하여 본 발명 고분자전해질 복합체의 세포적합성을 조사하는 단계로 구성된다.The present invention provides a method for preparing a colloidal chitosan / poly gamma glutamic acid polyelectrolyte complex by mixing chitosan as a cationic polymer and poly gamma glutamic acid as an anionic polymer at a constant pH; Preparing a scaffold using the colloidal polyelectrolyte complex; Preparing a film using the colloidal polymer electrolyte composite and investigating its mechanical properties; And using the scaffold prepared above is composed of the step of examining the cell suitability of the polymer electrolyte complex of the present invention.

본 발명에 따른 고분자전해질 복합체의 조성은 키토산과 폴리 감마 글루탐산을 1∼30 w/v 또는 v/v %로 블렌드시킴을 특징으로 한다.The composition of the polymer electrolyte composite according to the present invention is characterized by blending chitosan and poly gamma glutamic acid at 1 to 30 w / v or v / v%.

본 발명 키토산/폴리 감마 글루탐산 고분자전해질 복합체의 제조방법은 다음의 단계를 포함한다:The method for preparing chitosan / poly gamma glutamic acid polyelectrolyte composite of the present invention comprises the following steps:

게, 새우등의 껍질로부터 단백질 제거(약 알카리 처리), 칼슘 제거(희염산 처리), 색소 제거 공정을 거쳐 키틴을 탈아세틸화시켜 키토산을 얻고, Deacetylation of chitin through protein removal (weak alkaline treatment), calcium removal (dilute hydrochloric acid treatment), pigment removal from shells such as crabs and shrimps to obtain chitosan,

바실러스 속 균주 배양물에서 폴리 감마 글루탐산을 분리 정제하고,Isolate and purify poly gamma glutamic acid from Bacillus strain culture,

상기 키토산을 양이온성 고분자로, 폴리 감마 글루탐산을 음이온성 고분자로 사용하여 키토산과 폴리 감마 글루탐산의 혼합비율이 100:1∼100:30 또는 99:1∼70:30 w/v 또는 v/v %이 되도록 혼합하여 pH 4∼5에서 1 v/v% 아세트산에 최종 1 w/v%가 되도록 녹여 콜로이드성 키토산/폴리 감마 글루탐산 고분자전해질 복합체를 얻음.The mixing ratio of chitosan and poly gamma glutamic acid is 100: 1 to 100: 30 or 99: 1 to 70:30 w / v or v / v% using the chitosan as a cationic polymer and poly gamma glutamic acid as the anionic polymer. Mixing so as to dissolve in 1 v / v% acetic acid to a final 1 w / v% at pH 4 to 5 to obtain a colloidal chitosan / poly gamma glutamic acid polyelectrolyte complex.

본 발명 키토산/폴리 감마 글루탐산 고분자전해질 복합체의 제조방법에 있어서 키토산과 폴리 감마 글루탐산을 녹이는 용매의 pH 범위는 4∼5가 적당한데, 이보다 높을 경우 키토산이 침전되고, 이보다 낮을 경우 폴리 감마 글루탐산이 침전된다.In the preparation method of the chitosan / poly gamma glutamic acid polyelectrolyte composite of the present invention, the pH range of the solvent dissolving chitosan and poly gamma glutamic acid is 4 to 5, and if higher than this, chitosan is precipitated, and if lower than this, polygamma glutamic acid is precipitated. do.

본 발명 키토산/폴리 감마 글루탐산 고분자전해질 복합체의 제조방법에 있어서 키토산과 폴리 감마 글루탐산의 혼합비율은 100:1∼100:30 또는 99:1∼70:30이 w/v 또는 v/v %이 적당하며 이보다 낮을 경우 고분자전해질 복합체의 성질이 현저히 떨어지며, 이보다 높을 경우 침전이 일어나 재료를 컨트롤하기 힘들어진다. In the preparation method of the chitosan / poly gamma glutamic acid polymer electrolyte composite, the mixing ratio of chitosan and poly gamma glutamic acid is 100: 1 to 100: 30 or 99: 1 to 70:30, where w / v or v / v% is suitable. If it is lower than this, the properties of the polymer electrolyte composite are significantly decreased, and if it is higher than this, precipitation occurs and it becomes difficult to control the material.

상기 키토산/폴리 감마 글루탐산 고분자전해질 복합체의 제조방법에 따라 얻은 고분자전해질 복합체를 스폰지, 필름 등의 응용품으로 제조할 경우 에탄올과 dH2O로 아세트산을 씻어주는 과정이 필수되어야 한다.When preparing the polymer electrolyte composite obtained according to the chitosan / poly gamma glutamic acid polyelectrolyte composite prepared by an application such as a sponge or a film, a process of washing acetic acid with ethanol and dH 2 O should be essential.

본 발명에 따른 키토산/폴리 감마 글루탐산 고분자전해질 복합체는 종래의 생체재료보다 비용이 저렴하면서 의학적으로 응용될 수 있는 성질을 대부분 가지고 있기 때문에 상처의 드레싱, 세포배양용 스캐폴드, 인공신장의 혈액 투석막, 인공폐의 막, 각막이식재료 또는 콘택트렌즈재료, 조직적합성 및 혈액적합성재료 등의 다양한 분야에서 응용가능하다. Chitosan / poly-gamma glutamic acid polyelectrolyte complex according to the present invention is cheaper than conventional biomaterials and has most properties that can be applied medically, so dressing of wound, scaffold for cell culture, hemodialysis membrane of artificial kidney, It can be applied in various fields such as membrane of artificial lung, corneal graft material or contact lens material, tissue compatibility and blood compatibility material.

본 발명의 고분자전해질 복합체의 형성 여부는 수용액에 복합체를 분산시켜 UV/VIS 분광광도계(MECASYS, Opizen 2120UV)를 사용하여 500 nm에서 탁도(turbidity)를 측정하여 확인하였다. HITACHI S-3500N SEM 기계를 통하여 고분자전해질 복합체로 제조된 스캐폴드의 미세구조를 관찰하였으며, 재료의 기계적 특성 테스트, 세포적합성 테스트(cytocompatibility test)를 수행하여 의료용 상품으로서의 응용가능성을 조사하였다.The formation of the polymer electrolyte complex of the present invention was confirmed by dispersing the complex in an aqueous solution and measuring turbidity at 500 nm using a UV / VIS spectrophotometer (MECASYS, Opizen 2120UV). The microstructure of the scaffold made of the polymer electrolyte composite was observed through a HITACHI S-3500N SEM machine, and the mechanical property test and the cytocompatibility test were performed to investigate the applicability as a medical product.

이하, 본 발명의 구체적인 방법을 실시예를 들어 상세히 설명하고자 하지만 본 발명의 권리범위는 이들 실시예에만 한정되는 것은 아니다.Hereinafter, the specific method of the present invention will be described in detail with reference to Examples, but the scope of the present invention is not limited only to these Examples.

[실시예]EXAMPLE

실시예 1: 본 발명 키토산/폴리 감마 글루탐산 고분자전해질 복합체의 제조Example 1 Preparation of the Chitosan / Poly Gamma Glutamic Acid Polyelectrolyte Composite of the Invention

본 발명 키토산/폴리 감마 글루탐산 고분자전해질 복합체의 제조하기 위해 게, 새우등의 껍질로부터 단백질 제거(약 알카리 처리), 칼슘 제거(희염산 처리), 색소 제거 공정을 거쳐 키틴을 탈아세틸화시켜 키토산을 얻고, 바실러스 속 균주 배양물에서 폴리 감마 글루탐산을 분리 정제하였다. 상기 키토산과 폴리 감마 글루탐산의 혼합비율이 100:1∼100:30 또는 99:1∼70:30 w/v 또는 v/v %이 되도록 혼합하여 pH 4∼5에서 1 v/v% 아세트산에 최종 1 w/v%가 되도록 녹였다.To prepare chitosan / poly gamma glutamic acid polyelectrolyte complex of the present invention, chitin is deacetylated through protein removal (weak alkaline treatment), calcium removal (dilute hydrochloric acid treatment), pigment removal process from shells of crab, shrimp, etc. to obtain chitosan, Poly gamma glutamic acid was isolated and purified from Bacillus strain culture. The mixture ratio of chitosan and poly gamma glutamic acid is 100: 1 to 100: 30 or 99: 1 to 70:30 w / v or v / v%, and the final mixture is mixed with 1 v / v% acetic acid at pH 4-5. Dissolved to 1 w / v%.

실험예 1: 키토산/폴리 감마 글루탐산의 혼합비율에 따른 고분자전해질 복합체의 콜로이드(stable turbid dispersion) 형성 정도Experimental Example 1: The degree of colloid (stable turbid dispersion) formation of the polymer electrolyte composite according to the mixing ratio of chitosan / poly gamma glutamic acid

키토산/폴리 감마 글루탐산의 혼합비율에 따른 고분자전해질 복합체의 콜로이드(stable turbid dispersion) 형성 정도를 알아보기 위해, 실시예 1에 따라 키토산과 폴리 감마 글루탐산의 혼합비율을 높여가면서 UV/VIS 분광광도계(MECASYS, Opizen 2120UV)를 사용하여 500 nm에서 탁도를 측정하였다.In order to determine the degree of colloidal (stable turbid dispersion) formation of the polymer electrolyte complex according to the mixing ratio of chitosan / poly gamma glutamic acid, while increasing the mixing ratio of chitosan and poly gamma glutamic acid according to Example 1, a UV / VIS spectrophotometer (MECASYS , Opizen 2120UV) was used to measure turbidity at 500 nm.

도 1에 나타난 바와 같이, 혼합비율 100/30까지는 콜로이드(stable turbid dispersion)를 형성하였으나 그 이상의 혼합비율에서는 침전이 일어나는 것을 알 수 있었다.As shown in Figure 1, up to a mixing ratio of 100/30 to form a colloid (stable turbid dispersion) it was found that the precipitation occurs at a higher mixing ratio.

실험예 2: pH 변화에 따른 키토산/폴리 감마 글루탐산 고분자전해질 복합체의 콜로이드(stable turbid dispersion) 형성 정도Experimental Example 2: The degree of colloid (stable turbid dispersion) formation of chitosan / poly gamma glutamic acid polyelectrolyte complex with pH change

pH 변화에 따른 키토산/폴리 감마 글루탐산 고분자전해질 복합체의 콜로이드(stable turbid dispersion) 형성 정도를 알아보기 위해, pH1부터 10M NaOH 용액으로 pH10까지 적정하면서 UV/VIS 분광광도계(MECASYS, Opizen 2120UV)를 사용하여 500 nm에서 탁도를 측정하였다.To determine the degree of colloidal (stable turbid dispersion) formation of chitosan / poly gamma glutamic acid polyelectrolyte complex with pH change, using a UV / VIS spectrophotometer (MECASYS, Opizen 2120UV) while titrating from pH1 to pH10 with 10M NaOH solution Turbidity was measured at 500 nm.

도 2에 나타난 바와 같이, pH 1.2에서 5.5사이에서 콜로이드(stable turbid dispersion)를 형성하였으며 pH 4.3에서 가장 큰 탁도를 나타내었다. pH 5.5이상에서는 침전이 일어났다.As shown in FIG. 2, colloidal (stable turbid dispersion) was formed between pH 1.2 and 5.5 and showed the highest turbidity at pH 4.3. Precipitation occurred above pH 5.5.

실시예 2: 본 발명 키토산/폴리 감마 글루탐산 고분자전해질 복합체를 이용하여 제조한 스캐폴드Example 2 Scaffolds Prepared Using the Chitosan / Poly Gamma Glutamic Acid Polyelectrolyte Composites of the Invention

상기 실시예 1에 따른 콜로이드성(stable turbid dispersion) 키토산/폴리 감마 글루탐산 고분자전해질 복합체를 -20℃에서 얼린 후 동결건조하여 스캐폴드를 제조한 다음, 100% EtOH, 70% EtOH, 50% EtOH로 충분히 씻어준 후 마지막으로 dH2O로 씻고, 다시 동결건조하여 건조된 형태의 스캐폴드를 제조하였다. 제조된 스캐폴드를 SEM사진을 찍어 미세구조를 관찰하였다. 도 3의 (a)는 키토산으로 제조된 스캐폴드이고, (b)는 키토산/폴리 감마 글루탐산의 혼합비율이 100/1인 고분자전해질 복합체로 제조된 스캐폴드이고, (c)는 키토산/폴리 감마 글루탐산의 혼합비율이 100/10인 고분자전해질 복합체로 제조된 스캐폴드이고, (d)는 키토산/폴리 감마 글루탐산의 혼합비율이 100/30인 고분자전해질 복합체로 제조된 스캐폴드를 나타낸 것이다. The colloidal (stable turbid dispersion) chitosan / poly gamma glutamic acid polymer electrolyte composite according to Example 1 was frozen at -20 ° C and lyophilized to prepare a scaffold, followed by 100% EtOH, 70% EtOH, 50% EtOH. After washing sufficiently, the mixture was finally washed with dH 2 O, and lyophilized to prepare a dried scaffold. The microstructure was observed by taking a SEM photograph of the prepared scaffold. Figure 3 (a) is a scaffold made of chitosan, (b) is a scaffold made of a polyelectrolyte complex having a mixing ratio of chitosan / poly gamma glutamic acid 100/1, (c) is chitosan / poly gamma A scaffold made of a polymer electrolyte complex having a mixing ratio of glutamic acid of 100/10, and (d) shows a scaffold made of a polymer electrolyte composite having a mixing ratio of chitosan / poly gamma glutamic acid of 100/30.

도 4는 키토산/폴리 감마 글루탐산의 혼합비율에 따른 고분자전해질 복합체의 세공크기를 나타냈다.Figure 4 shows the pore size of the polymer electrolyte composite according to the mixing ratio of chitosan / poly gamma glutamic acid.

도 3에 나타난 바와 같이, 키토산 스캐폴드 보다 고분자전해질 복합체를 사용하여 제조된 스캐폴드에서 세공의 균일 정도가 상당히 증가된 것을 볼 수 있으며, 도 4에서 세공 크기는 키토산/폴리 감마 글루탐산의 혼합비율이 증가할수록 작아지는 것을 관찰할 수 있다.As shown in Figure 3, it can be seen that the uniformity of the pores in the scaffold prepared using the polymer electrolyte complex than the chitosan scaffold is significantly increased, the pore size in Figure 4 is a mixture ratio of chitosan / poly gamma glutamic acid It can be observed that as it increases, it decreases.

실시예 3: 본 발명 키토산/폴리 감마 글루탐산 고분자전해질 복합체를 이용하여 제조한 필름을 이용한 기계적 특성 조사Example 3: Investigation of mechanical properties using a film prepared using the present invention chitosan / poly gamma glutamic acid polymer electrolyte composite

상기 실시예 1에 따른 콜로이드성(turbid dispersion) 키토산/폴리 감마 글루탐산 고분자전해질 복합체를 이용하여 필름을 제조하고 이 필름의 기계적 특성을 조사하였다. 키토산/폴리 감마 글루탐산 콜로이드(turbid dispersion)를 실온에서 자연건조하여 100% EtOH, 70% EtOH, 50% EtOH로 충분히 씻고 마지막으로 dH2O로 씻어준 후 다시 자연건조하여 건조된 형태의 필름을 제조하여 인장강도(tensile strength)를 측정하였다. A film was prepared using the colloidal (turbid dispersion) chitosan / poly gamma glutamic acid polymer electrolyte composite according to Example 1 and the mechanical properties of the film were investigated. The chitosan / poly gamma glutamic acid colloid (turbid dispersion) was naturally dried at room temperature, thoroughly washed with 100% EtOH, 70% EtOH, 50% EtOH, and finally with dH 2 O, and then dried again to prepare a dried film. Tensile strength was measured.

도 5에 나타난 바와 같이, 키토산/폴리 감마 글루탐산의 혼합비율이 증가할수록 인장강도가 증가하는 것을 볼 수 있었다.As shown in FIG. 5, it was found that the tensile strength increased as the mixing ratio of chitosan / poly gamma glutamic acid increased.

실시예 4: 본 발명 키토산/폴리 감마 글루탐산 고분자전해질 복합체로 제조된 스캐폴드의 세포적합성Example 4 Cell Compatibility of Scaffolds Prepared with Inventive Chitosan / Poly Gamma Glutamic Acid Polyelectrolyte Complexes

본 발명 키토산/폴리 감마 글루탐산 고분자전해질 복합체로 제조된 스캐폴드의 세포적합성을 조사하기 위해, 키토산/폴리 감마 글루탐산 고분자전해질 복합체로 제조된 스캐폴드와 키토산으로 제조된 스캐폴드에서 NHDF(Normal Human Dermal Fibroblast)를 배양하여 MTT 분석을 통하여 세포수를 측정하였다. 도 6(a)는 세포 부착을 측정한 결과이고, (b)는 세포 증식(cell proliferation)을 측정한 결과를 나타낸 것이다. In order to investigate the cellular suitability of the scaffold made of chitosan / poly gamma glutamic acid polyelectrolyte complex, NHDF (Normal Human Dermal Fibroblast) in scaffold made of chitosan / poly gamma glutamic acid polyelectrolyte complex and scaffold made of chitosan ) Was cultured and the cell number was measured by MTT analysis. Figure 6 (a) is the result of measuring the cell adhesion, (b) shows the result of measuring the cell proliferation (cell proliferation).

도 6에 나타난 바와 같이, 세포 부착 테스트에서는 키토산과 고분자전해질 복합체의 별다른 차이점을 발견하지 못하였다. 세포 증식 테스트에서는 고분자전해질 복합체로 제조된 스캐폴드가 키토산 스캐폴드와 비교하여 모두 더 많은 세포 증식을 나타냈으며, 키토산/폴리 글루탐산의 혼합비율이 100/10과 100/20에서 가장 크게 나타났고, 그 이상의 혼합비율에서는 세포 증식이 감소하였다.As shown in Figure 6, the cell adhesion test did not find any difference between the chitosan and the polymer electrolyte complex. In the cell proliferation test, the scaffolds prepared with the polyelectrolyte complex showed more cell proliferation compared to the chitosan scaffold, and the chitosan / polyglutamic acid mixing ratio was the highest at 100/10 and 100/20. In the above mixing ratio, cell proliferation was decreased.

상기 실시예 및 실험예를 통하여 살펴본 바와 같이, 본 발명은 키토산/폴리 감마 글루탐산 고분자전해질 복합체의 제조방법에 관한 것으로, 키토산의 생체적합성, 항미생물성, 생분해성 등 우수한 기능을 간직하며, 키토산으로 스폰지나 필름 등을 만들 경우 나타나는 구조적, 물리적 결함을 극복하여 높은 기계적 특성, 구조적 균일성, 높은 세포 친화력, 높은 팽윤(swelling) 등의 우수한 성질을 나타내는 키토산/폴리 감마 글루탐산 고분자전해질 복합체의 제조방법을 제공하는 뛰어난 효 과가 있다.As described through the above Examples and Experimental Examples, the present invention relates to a method for preparing chitosan / poly gamma glutamic acid polymer electrolyte composite, and retains excellent functions such as biocompatibility, antimicrobial, biodegradability of chitosan, A method for preparing a chitosan / poly gamma glutamic acid polymer electrolyte composite exhibiting excellent properties such as high mechanical properties, structural uniformity, high cell affinity, and high swelling by overcoming the structural and physical defects that appear when making a sponge or film. There is an outstanding effect.

또한, 본 발명 키토산/폴리 감마 글루탐산 고분자전해질 복합체는 상처의 드레싱, 세포배양용 스캐폴드, 인공신장의 혈액 투석막, 인공폐의 막, 각막이식재료 또는 콘택트렌즈재료, 조직적합성 및 혈액적합성재료 등의 다양한 분야에 응용될 수 있어 생체재료산업상 매우 유용한 발명이다.In addition, the present invention chitosan / poly gamma glutamic acid polyelectrolyte complex, such as wound dressing, cell culture scaffold, artificial kidney hemodialysis membrane, artificial lung membrane, corneal graft material or contact lens material, tissue compatibility and blood compatibility material It can be applied to various fields and is a very useful invention in the biomaterials industry.

Claims (3)

게, 새우등의 껍질로부터 단백질 제거(약 알카리 처리), 칼슘 제거(희염산 처리), 색소 제거 공정을 거쳐 키틴을 탈아세틸화시켜 키토산을 얻고, Deacetylation of chitin through protein removal (weak alkaline treatment), calcium removal (dilute hydrochloric acid treatment), pigment removal from shells such as crabs and shrimps to obtain chitosan, 바실러스 속 균주 배양물에서 분리 정제하여 폴리 감마 글루탐산을 얻고,Isolate and purify in Bacillus strain culture to obtain poly gamma glutamic acid, 상기 키토산을 양이온성 고분자로, 폴리 감마 글루탐산을 음이온성 고분자로 사용하여 키토산과 폴리 감마 글루탐산의 혼합비율이 100:1∼100:30 또는 99:1∼70:30 w/v 또는 v/v %이 되도록 혼합하여 pH 4∼5에서 1 v/v% 아세트산에 최종 1 w/v%가 되도록 녹여 콜로이드성 고분자전해질 복합체를 얻음을 특징으로 하는 키토산/폴리 감마 글루탐산 고분자전해질 복합체의 제조방법.The mixing ratio of chitosan and poly gamma glutamic acid is 100: 1 to 100: 30 or 99: 1 to 70:30 w / v or v / v% using the chitosan as a cationic polymer and poly gamma glutamic acid as the anionic polymer. Method of producing a chitosan / poly gamma glutamic acid polyelectrolyte composite, characterized in that the mixture is dissolved so that the final 1 w / v% in 1 v / v% acetic acid at pH 4 to 5 to obtain a colloidal polyelectrolyte complex. 제 1항 기재의 방법에 따라 제조됨을 특징으로 하는 키토산/폴리 감마 글루탐산 고분자전해질 복합체.A chitosan / poly gamma glutamic acid polyelectrolyte complex, which is prepared according to the method of claim 1. 키토산과 폴리 감마 글루탐산의 혼합비율이 100:1∼100:30 또는 99:1∼70:30 w/v 또는 v/v %인 키토산/폴리 감마 글루탐산 고분자전해질 복합체로 제조됨을 특징으로 하는 스캐폴드.A scaffold comprising chitosan / poly gamma glutamic acid polyelectrolyte composite having a mixing ratio of chitosan and poly gamma glutamic acid of 100: 1 to 100: 30 or 99: 1 to 70:30 w / v or v / v%.
KR1020040051301A 2004-07-01 2004-07-01 A method for preparing chitosan/poly ?-glutamic acid polyelectrolyte complex KR100691869B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020040051301A KR100691869B1 (en) 2004-07-01 2004-07-01 A method for preparing chitosan/poly ?-glutamic acid polyelectrolyte complex

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020040051301A KR100691869B1 (en) 2004-07-01 2004-07-01 A method for preparing chitosan/poly ?-glutamic acid polyelectrolyte complex

Publications (2)

Publication Number Publication Date
KR20060002331A true KR20060002331A (en) 2006-01-09
KR100691869B1 KR100691869B1 (en) 2007-03-12

Family

ID=37105295

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020040051301A KR100691869B1 (en) 2004-07-01 2004-07-01 A method for preparing chitosan/poly ?-glutamic acid polyelectrolyte complex

Country Status (1)

Country Link
KR (1) KR100691869B1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100845002B1 (en) * 2007-02-23 2008-07-08 부산대학교 산학협력단 Biodegradable porous composite of dual porosity and method for preparing the same
CN107586403A (en) * 2017-08-18 2018-01-16 天津北洋百川生物技术有限公司 A kind of γ polyglutamic acids chitosan gel rubber and its preparation method and application
KR20190080845A (en) * 2019-06-27 2019-07-08 영남대학교 산학협력단 Polyelectrolyte complexes comprising chitosan and Cosmetic Composition for using thereby
CN113069591A (en) * 2021-03-29 2021-07-06 黄河三角洲京博化工研究院有限公司 Chitosan-calcium polyglutamate biological dressing and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05117111A (en) * 1991-10-26 1993-05-14 Iatron Lab Inc Polyelectrolyte complex antimicrobial agent and antimicrobial material
JP2790786B2 (en) * 1995-10-16 1998-08-27 利夫 佐藤 Skin protective agent and method for producing the same
JPH11276572A (en) 1998-03-31 1999-10-12 Kanegafuchi Chem Ind Co Ltd Material for medical care made of poly(gamma-glutamic acid) salt complex
KR100466480B1 (en) * 2001-11-07 2005-01-15 제주대학교 산학협력단 Biodegradable interpolymer of gamma-poly(glutamic acid) and chitosan and manufactured film using the same

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100845002B1 (en) * 2007-02-23 2008-07-08 부산대학교 산학협력단 Biodegradable porous composite of dual porosity and method for preparing the same
CN107586403A (en) * 2017-08-18 2018-01-16 天津北洋百川生物技术有限公司 A kind of γ polyglutamic acids chitosan gel rubber and its preparation method and application
KR20190080845A (en) * 2019-06-27 2019-07-08 영남대학교 산학협력단 Polyelectrolyte complexes comprising chitosan and Cosmetic Composition for using thereby
CN113069591A (en) * 2021-03-29 2021-07-06 黄河三角洲京博化工研究院有限公司 Chitosan-calcium polyglutamate biological dressing and preparation method thereof

Also Published As

Publication number Publication date
KR100691869B1 (en) 2007-03-12

Similar Documents

Publication Publication Date Title
Douglass et al. A review of cellulose and cellulose blends for preparation of bio-derived and conventional membranes, nanostructured thin films, and composites
Chang et al. Physical properties of bacterial cellulose composites for wound dressings
Meng et al. Chitosan/alginate/hyaluronic acid polyelectrolyte composite sponges crosslinked with genipin for wound dressing application
Kumar A review of chitin and chitosan applications
Padil et al. Electrospun fibers based on Arabic, karaya and kondagogu gums
Yang et al. Structure and microporous formation of cellulose/silk fibroin blend membranes: I. Effect of coagulants
KR102443837B1 (en) Production of poly alpha-1,3-glucan films
Mao et al. Effects of coagulants on porous structure of membranes prepared from cellulose in NaOH/urea aqueous solution
Sang et al. Fabrication and evaluation of biomimetic scaffolds by using collagen–alginate fibrillar gels for potential tissue engineering applications
CN109821061B (en) Adhesive bionic gel with collagen spinning and hyaluronic acid as base materials
Horn et al. Influence of collagen addition on the thermal and morphological properties of chitosan/xanthan hydrogels
Rekik et al. Enhancing hydrophilicity and permeation flux of chitosan/kaolin composite membranes by using polyethylene glycol as porogen
WO2009035414A1 (en) Chitosan construct and method of preparing the same
Zhang et al. Self-assembly of chitosan and cellulose chains into a 3D porous polysaccharide alloy films: Co-dissolving, structure and biological properties
JPH04275346A (en) Compatibel mixture containing chitosan
Mhatre et al. Chitosan/gelatin/PVA membranes for mammalian cell culture
CN114470330A (en) Recombinant collagen gel particles for tissue filling and preparation method thereof
Zhou et al. Crosslinked ionic alginate and cellulose-based hydrogels for photoresponsive drug release systems
KR100691869B1 (en) A method for preparing chitosan/poly ?-glutamic acid polyelectrolyte complex
Yao et al. Novel cellulose-gelatin composite films made from self-dispersed microgels: Structure and properties
JPS6059123A (en) Production of chitosan fiber
CN110028685A (en) A kind of preparation method of fibroin/chitosan/porous oxidation graphene complex three-dimensional bracket
CN110028703A (en) A kind of preparation method of nano biological matter base high-strength and high-transparent degree large format composite membrane
EP1704182A1 (en) Compositions of semi-interpenetrating polymer network
CN106750575B (en) Hydroxypropyl chitosan/soybean protein isolate composite membrane and the preparation method and application thereof

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
N231 Notification of change of applicant
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130207

Year of fee payment: 7

FPAY Annual fee payment

Payment date: 20131231

Year of fee payment: 8

LAPS Lapse due to unpaid annual fee